Weber, M., Pettersson, O., Seifert, R., Schaarschmidt, B. M., Fendler, W. P., Rischpler, C., . . . Sundin, A. (2024). Changes in Tumor-to-Blood Ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT. European Journal of Nuclear Medicine and Molecular Imaging, 51, 841. https://doi.org/10.1007/s00259-023-06502-y
Chicago-referens (17:e uppl.)Weber, Manuel, Olof Pettersson, Robert Seifert, Benedikt Michael Schaarschmidt, Wolfgang Peter Fendler, Christoph Rischpler, Harald Lahner, Ken Herrmann, och Anders Sundin. "Changes in Tumor-to-Blood Ratio as a Prognostic Marker for Progression-free Survival and Overall Survival in Neuroendocrine Tumor Patients Undergoing PRRT." European Journal of Nuclear Medicine and Molecular Imaging 51 (2024): 841. https://doi.org/10.1007/s00259-023-06502-y.
MLA-referens (9:e uppl.)Weber, Manuel, et al. "Changes in Tumor-to-Blood Ratio as a Prognostic Marker for Progression-free Survival and Overall Survival in Neuroendocrine Tumor Patients Undergoing PRRT." European Journal of Nuclear Medicine and Molecular Imaging, vol. 51, 2024, p. 841, https://doi.org/10.1007/s00259-023-06502-y.
